Senior insider sale
General Counsel at MEREO BIOPHARMA GROUP PLC — senior position signals high conviction
$203.1K
51.03K shares
What this filing means
SERMON CHARLES plans to sell 51.03K shares of MEREO BIOPHARMA GROUP PLC valued at approximately $203.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/20/2024ACC: 0000950170-24-075637
Officer· General Counsel
Since Feb 2026
51.03K
Shares to sell
$203.1K
Approx. market value
98.40K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Same Day Cashless Exercise and Sale
Equity Compensation
6/21/2024
98.40KTotal acquired98.40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/21/2024 | Same Day Cashless Exercise and Sale Equity Compensation | 98.40K | — |
| Total | 98.40K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
51.03K
Market value
$203.1K
6/21/2024
Total
Units
51.03K
Value
$203.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/21/2024 | 51.03K | $203.1K | Nasdaq | Planned |
| Total | 51.03K | $203.1K | ||